| Trial ID: | L5807 |
| Source ID: | NCT00437970
|
| Associated Drug: |
Pioglitazone
|
| Title: |
Medication in Early Diabetes (MED) Study
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Pioglitazone|DRUG: Metformin
|
| Outcome Measures: |
Primary: HbA1c values, second monthly|Weight gain, monthly|Weight distribution, six monthly|Medication side effects, monthly | Secondary: Medication compliance, monthly|Side effects, monthly|Lipids, second monthly|Endothelial dysfunction., second monthly
|
| Sponsor/Collaborators: |
Sponsor: Menzies School of Health Research
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-04
|
| Completion Date: |
2009-02
|
| Results First Posted: |
|
| Last Update Posted: |
2016-05-27
|
| Locations: |
Menzies School of Health Research, Darwin, Northern Territory, 0810, Australia
|
| URL: |
https://clinicaltrials.gov/show/NCT00437970
|
